Status:
COMPLETED
Adults With Moderate to Severe Asthma
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
A study to compare the safety and effectiveness of 5 different ways of taking Pulmicort when given to asthma patients aged 12 years and above.
Eligibility Criteria
Inclusion
- Male or female aged 12 or over who have asthma
- Ability to properly use an electronic diary
- Able and willing to nebulize for up to 20 minutes every morning and evening
Exclusion
- Hospitalised at least one once or required emergency treatment due to asthma in the previous 6 months
- Planned hospitalisation during the study
- pregnant women or women planning to become pregnant
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2004
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT00642122
Start Date
April 1 2003
End Date
December 1 2004
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.